Medicare Enrolled

Dr. Sumesh Chandra, MD

Endocrinology · Tampa, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
13801 BRUCE B DOWNS BLVD STE 201, Tampa, FL 33613
8139775557
Registered in NPPES since 2005
NPI: 1477547602 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chandra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chandra

Dr. Sumesh Chandra is an endocrinology specialist in Tampa, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Chandra performed 911 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Chandra received a total of $6,604 from 30 pharmaceutical and/or device companies across 191 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chandra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 47% volume in FL $6,604 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 34899 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
911
Medicare services
Top 47% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
511 $88 $210
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
167 $132 $285
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
64 $78 $245
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $64 $145
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
41 $36 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
36 $105 $370
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
25 $98 $250
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
23 $100 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,604
Total received (2018-2024)
Avg $943/year across 7 years
Top 38% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
191
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$856
2023
$531
2022
$865
2021
$1,122
2020
$896
2019
$1,460
2018
$874

Payments by company (2024)

Bayer Healthcare Pharmaceuticals Inc.
$171
Kyowa Kirin, Inc.
$144
Novo Nordisk Inc
$134
SANOFI-AVENTIS U.S. LLC
$130
Abbott Laboratories
$58
Lilly USA, LLC
$51
ABBVIE INC.
$49
Insulet Corporation
$43
Corcept Therapeutics
$41
Dexcom, Inc.
$19
IBSA Pharma Inc.
$15
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,290
Novo Nordisk Inc
$696
SANOFI-AVENTIS U.S. LLC
$597
Radius Health, Inc.
$589
AstraZeneca Pharmaceuticals LP
$422
Bayer HealthCare Pharmaceuticals Inc.
$343
Abbott Laboratories
$256
Insulet Corporation
$221
Lilly USA, LLC
$220
Janssen Pharmaceuticals, Inc
$201
Bayer Healthcare Pharmaceuticals Inc.
$199
Dexcom, Inc.
$198
Corcept Therapeutics
$164
Kyowa Kirin, Inc.
$144
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
Amryt Pharma Holdings Ltd
$125
AbbVie Inc.
$113
RECORDATI_RARE_DISEASES_INC.
$85
DEXCOM, INC.
$79
ABBVIE INC.
$71
Medtronic, Inc.
$70
Gilead Sciences, Inc.
$64
Xeris Pharmaceuticals, Inc.
$64
Merck Sharp & Dohme Corporation
$57
Amneal Pharmaceuticals LLC
$49
AbbVie, Inc.
$43
Shire North American Group Inc
$37
Medtronic MiniMed, Inc.
$34
Antares Pharma, Inc.
$16
IBSA Pharma Inc.
$15
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
Androgel · BAQSIMI · BYDUREON · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · OTREXUP · Omnipod · Ozempic · Prolia · RETEVMO · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SYNTHROID · TOUJEO · TRADJENTA · TZIELD · Tirosint · Tresiba · Truvada · Tymlos · UBRELVY · UNITHROID · Wegovy · XARELTO · Xofigo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Tampa?
Compare endocrinologists in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
74
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chandra is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chandra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chandra performed 511 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chandra receive payments from pharmaceutical companies?
Yes. Dr. Chandra received a total of $6,604 from 30 companies across 191 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chandra's costs compare to other endocrinologists in Tampa?
Dr. Chandra's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chandra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →